Enterococcus faecalis endocarditis in an immunocompetent patient: a case report
DOI:
https://doi.org/10.24265/horizmed.2024.v24n4.14Keywords:
Endocarditis, Bacterial , Infective Endocarditis , Aortic Valve Disease , Enterococcus faecalisAbstract
Infective endocarditis is a disease characterized by inflammation of the endocardium secondary to the entry of pathogens into the circulation, which may include bacteria, fungi and even viruses. Its etiology may vary among microorganisms; however, Enterococcus faecalis bacteria is the third most frequent, after S. aureus and S. pyogenes. For each of these causative agents of the disease, it is necessary to assess the appropriate treatment aimed at eradicating the microorganism, based on the international guidelines of the European Society of Cardiology (ESC), institutional parameters and local epidemiology. We present the case of a 44-year-old man of African descent with no comorbidities, whose only significant history includes dental procedures in the context of Enterococcus faecalis infective endocarditis. With this case, we aim to give visibility to the causative microorganism and the clinical picture for which the patient consulted, highlighting pathognomonic and non-pathognomonic clinical signs of the disease. It is also important to emphasize the need to promptly initiate antibiotic therapy, suspect the disease, exclude multiple differential diagnoses and perform early surgical management, as all of these can influence the prognosis and outcome of the patient, with death being the most serious of these. Likewise, we intend to provide guidance to healthcare professionals who may face similar cases. Finally, we would like to emphasize to emphasize the importance of effective communication between institutions, as there may be delays due to transfers, the need to repeat paraclinical and imaging test to confirm the diagnosis, and delays in surgical management due to a lack of necessary resources, which can lead to the worsening of the disease.
Downloads
References
Chidurala S, Bheemarasetti M. Unusual Presentation of Infective Endocarditis Following a Prostatic Urethral Lift. Cureus [Internet]. 2022;14(7):e26919.
López Rodríguez JA, Flores Sigüenza JB, Ríos Verdugo PD, Rivera González SC, Córdova Feijoo MA, Serrano Piedra DP, et al. Caso Clínico: Endocarditis Bacteriana de Válvula Aórtica Nativa. Rev Médica HJCA. 2017;9(2):186-90.
Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H, et al. 2023 ESC Guidelines for the management of endocarditis of the European Society of Cardiology (ESC) Endorsed by European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM). Eur Heart J [Internet]. 2023;44(39):3948–4042.
Aguirre Fernández D, Naanous Rayek J, Vélez Pintado M, Soto RJ. Endocarditis infecciosa por Enterococcus faecalis. [Internet]. 2019;64:49–52.
Dahl A, Iversen K, Tonder N, Hoest N, Arpi M, Dalsgaard M, et al. Prevalence of Infective Endocarditis in Enterococcus faecalis Bacteremia. J Am Coll Cardiol. 2019;74(2):193–201.
Fernández-Hidalgo N, Almirante B. Infective endocarditis in the XXI century: Epidemiological, therapeutic, and prognosis changes. Enferm Infecc Microbiol Clin [Internet]. 2012;30(7):394–406.
Pericàs JM, Llopis J, Muñoz P, Gálvez-Acebal J, Kestler M, Valerio M, et al. A Contemporary Picture of Enterococcal Endocarditis. J Am Coll Cardiol [Internet]. 2020;75(5):482–94.
Osler W. The Glutotian Lectures, on Malignant Endocarditsa. Br Med J [Internet]. 1885;(1262):467–70.
Pericas JM, Cervera C, del Rio A, Moreno A, Garcia de la Maria C, Almela M, et al. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone. Clin Microbiol Infect. 2014;20(12):O1075–83.
Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, De Alarcón A, et al. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis. Clin Infect Dis [Internet]. 2013;56(9):1261–8.
De Almeida CV, Lulli M, Di Pilato V, Schiavone N, Russo E, Nannini G, et al. Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis’ Strains Isolated from Healthy Donors and Colorectal Cancer Patients. J Clin Med [Internet]. 2019;8(3):388.
Murdoch DR, Corey RG, Hoen B, Miró M, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on Endocarditisprospective cohort study. Arch Intern Med [Internet]. 2009;169(5):46373.
Escolá Vergé L. Estado actual de la endocarditis enterocócica [Tesis de posgrado]. Barcelona:UAB;2020. Recuperado a partir de: https://ddd.uab.cat/pub/tesis/2020/hdl_10803_670192/lev1de1.pdf
Ramos-Martínez A, Pericàs JM, Fernández-Cruz A, Muñoz P, Valerio M, Kestler M, et al. Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study. PLoS One. 2020;15(8):e0237011.
Jameson J, Fauci AS, Kaspe DL, Hauser SL, Longo DL, Loscalzo J. Harrison’s Principles of Internal Medicine, 20 ed. Madrid Disponible en: https://accessmedicine.mhmedical.com/content.aspx?bookid=2129&se ctionid=159213747
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Horizonte Médico (Lima)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).